
-
Sri Lanka counts nuisance wildlife in bid to protect crops
-
Cleveland cruise to record 16th straight win, Boston clinch
-
Sabalenka routs Keys, books Indian Wells title clash with teen Andreeva
-
Cuba suffers fourth nationwide blackout in five months
-
Piastri tops final Melbourne practice ahead of Russell
-
Sabalenka crushes Keys to reach Indian Wells final
-
Residents flee new wave of violence in Haiti capital
-
Starmer to host coalition call as he says Putin 'not serious about peace'
-
New nationwide blackout hits Cuba, officials say
-
Advantage France in three-way fight for Six Nations crown
-
Bangladeshi women alarmed by emboldened Islamists
-
Unification Church faces dissolution in Japan
-
Teen Andreeva topples defending champ Swiatek to reach Indian Wells final
-
Slot eyes first Liverpool trophy against Newcastle in League Cup final
-
Formula One boss to visit Thailand for talks on Bangkok race
-
Former Meta employee barred from promoting explosive memoir
-
Thomas ties course record with 62 as Lee, Bhatia lead Players
-
England boss Tuchel wants to 'earn right' to sing national anthem
-
Guardiola hits back at Capello over 'arrogant' jibe
-
Van Dijk won't 'panic' over Liverpool future
-
Alcaraz expects tough test from Draper in Indian Wells semi-finals
-
Injured Neymar out of Brazil World Cup qualifiers
-
Former Australia rugby captain Elsom handed two-year jail sentence
-
Trump blasts foes and media in speech at 'Department of Injustice'
-
Meta strives to stifle ex-employee memoir
-
US Congress clears key hurdle in bid to avert govt shutdown
-
Captain of ship in North Sea crash charged with manslaughter
-
Sean 'Diddy' Combs pleads not guilty to new indictment
-
Marc Marquez on top in Argentina MotoGP practice
-
Putin, Maduro vow to boost ties in wake of Trump sanctions
-
Sherratt says Wales need 'fresh' coach as Six Nations stint ends against England
-
New Canada PM Carney says Canada will never be part of US
-
Putin calls on Ukraine troops in Russian region to 'surrender'
-
Itoje urges England to 'take game to Wales' in Six Nations finale
-
Ebola-infected monkeys cured with a pill, raising hopes for humans: study
-
Mexicans seek answers after bones, shoes found at cartel camp
-
Triumphant Pedersen finds cold comfort on shivering 'Race to the Sun'
-
Greenland party leaders call Trump's behaviour 'unacceptable'
-
United G7 warns Russia to back Ukraine truce
-
Inothewayurthinkin beats Galopin Des Champs to win Cheltenham Gold Cup
-
Sebastian Coe criticises IOC election process
-
Israel PM, security agency fight it out in public
-
Courtois returns from Belgium exile for Nations League duty
-
Dupont absence 'changes nothing' for Alldritt before France's Six Nations decider
-
Russia 'committed crimes against humanity' in Ukraine: UN probe
-
Trump hails 'productive' truce talks with Russia, urges Putin to spare Ukrainians
-
Hundreds of Olympians call on IOC candidates to make climate top priority
-
Florence cathedral closed as Italy's Tuscany on flood alert
-
Mark Carney: Canada's new PM charted unusual path to power
-
Arteta 'proud' of Lewis-Skelly's England call-up

Ebola-infected monkeys cured with a pill, raising hopes for humans: study
Monkeys infected with Ebola can be cured with a pill, according to a new study out Friday that could pave the way for more practical, affordable treatments in humans.
First identified in 1976 and thought to have crossed over from bats, Ebola is a deadly viral disease spread through direct contact with bodily fluids, causing severe bleeding and organ failure.
Because outbreaks primarily affect sub-Saharan Africa, pharmaceutical companies have lacked financial incentives to develop treatments, and the sporadic nature of outbreaks has made clinical trials difficult.
A vaccine was only widely approved in 2019, and while two intravenous antibody treatments improve outcomes, they require costly cold storage and are difficult to administer in some of the world's poorest regions.
"We're really trying to come up with something that was more practical, easier to use, that could be used to help prevent, control, and contain outbreaks," Thomas Geisbert, a virologist at The University of Texas Medical Branch at Galveston, who led the new study published in Science Advances, told AFP.
For their experiment, Geisbert and colleagues tested the antiviral Obeldesivir, the oral form of intravenous Remdesivir, originally developed for Covid-19.
Obeldesivir is a "polymerase inhibitor," meaning it blocks an enzyme crucial for viral replication.
The team infected rhesus and cynomolgus macaques with a high dose of the Makona variant of the Ebola virus.
A day after exposure, ten monkeys then received an Obeldesivir pill daily for ten days, while three control monkeys received no treatment and died.
Obeldesivir protected 80 percent of the cynomolgus macaques and 100 percent of the rhesus macaques, which are biologically closer to humans.
The drug not only cleared the virus from the treated monkeys' blood but also triggered an immune response, helping them develop antibodies while avoiding organ damage.
Geisbert explained that while the number of monkeys was relatively small, the study was statistically powerful because they were exposed to an extraordinarily high dose of the virus -- roughly 30,000 times the lethal dose for humans. This reduced the need for additional control monkeys, limiting unnecessary animal deaths.
The researcher, who has worked on Ebola since the 1980s and is credited with discovering the Reston strain, said one of the most exciting aspects of Obeldesivir is its "broad-spectrum" protection, compared to the approved antibody treatments that only work against the Zaire species of Ebola.
"That's a huge advantage," Geisbert said.
Pharmaceutical maker Gilead is currently advancing Obeldesivir to Phase 2 clinical trials for Marburg virus, a close relative of Ebola.
Geisbert also emphasized the importance of funding from the US National Institutes of Health, amid reports that dozens of grants have been canceled under President Donald Trump's administration.
"All these drugs and vaccines that were developed against Ebola and a lot of these exotic viruses and pathogens -- 90 percent of the money comes from the US government," he said, adding, "I think the general public would agree we need treatments for Ebola."
T.Resende--PC